Loading…
This event has ended. Create your own event on Sched.
Welcome to the Science Summit at UNGA76, a major contribution to advancing Science for the UN SDGs. Online from 14- September - 5 October 2021.
ISC will organise the second edition of the UNGA76 Science Summit around the 76th United Nations General Assembly (SSUNGA76) in September 2021. The objective of the virtual meeting will be to raise awareness of the role and contribution of science to the attainment of the United Nations Sustainable Development Goals. It will demonstrate initiatives that provide models for global science mechanisms and activities in support of the SDGs, particularly in science infrastructure and capacity building. Science is and will enable sustainable economic, environmental, and societal development. Science is more than a funding prioritisation exercise: science is impacting all areas of policy-making and is playing a more critical role in how policy objectives are achieved and the consequent benefit to people everywhere, including responses to global challenges.
Engagement with policy leadership is more important than ever: UNGA76 is a unique forum for science to demonstrate how policy and political leadership can benefit from innovation. Central to this is the role of nonstate actors and the multilateral fora, which increasingly determine how priorities are set. Science needs to be part of this dialogue and inform outputs through thought leadership, evidence, insights, analysis, and innovation.

Registration is available here.
avatar for Zisis Kozlakidis

Zisis Kozlakidis

IARC/WHO
Head, Laboratory Services and Biobanking
Dr Zisis Kozlakidis,  Head of the Laboratory Services and Biobank Group at the International Agency for Research on Cancer (IARC), in Lyon, France, has been past President of the International Society for Biological and Environmental Repositories (ISBER), and Innovation Fellow at UCL, UK.
Dr Kozlakidis has significant expertise in the field of biobanking. Until recently he served as the President of ISBER, and he has been involved in the activities of BBMRI.uk. His ISBER presidency was instrumental in the closer collaboration between ISBER and BBMRI-ERIC, with the signing of a Memorandum of Understanding between the two organisations and the planning of many future joint activities. It is expected that this close collaboration will continue now that Dr Kozlakidis has taken up his position with IARC and BCNet, to the benefit of the biobanking field globally.
Dr Kozlakidis is a virologist, with a PhD in microbiology from Imperial College London. He is an elected Fellow of the Linnean Society of London, the Royal Academy of Sciences, UK, and a Turnberg Fellow of the UK Academy of Medical Sciences. Dr Kozlakidis has contributed to seminal studies in the adoption of innovations into routine healthcare, and their associated financial impacts (NHS Innovation, 2014: “The determinants for the adoption of innovation in the NHS”; PHG Foundation, 2015: “Pathogen genomics into practice”; WHO, 2016: “Ensuring innovation in diagnostics for bacterial infection”). He holds an Executive MBA degree from Cass Business School, City University, London, and he is a co-founder of the City Healthcare Innovation Network, a conduit for providing and strengthening contacts between healthcare start-ups and financial institutions based in the financial district of London.